Abstract

To establish the relationship between the dose of FE 999049, a novel recombinant FSH derived from a human cell-line (PER.C6) and the number of oocytes retrieved, and to characterize it according to serum AMH. Randomized, controlled, assessor-blind, multicentre, dose-response trial in 265 IVF/ICSI patients undergoing controlled ovarian stimulation with one of five doses of FE 999049 (Ferring Pharmaceuticals) or one dose of follitropin alfa (GONAL-F, EMD Serono) (NCT01426386). Patients were randomized to fixed doses of 5.2, 6.9, 8.6, 10.3 or 12.1 μg/day FE 999049 (N=222) or follitropin alfa 11 μg/day (150 IU/day) (N=43). Randomization was stratified by serum AMH (low: 5.0-14.9 pmol/L, high: 15.0-44.9 pmol/L; Beckmann-Coulter Gen 2 ELISA). Stimulation was carried out in a GnRH antagonist cycle (ganirelix 0.25 mg/day from day 6). Triggering was done when ≥3 follicles ≥17 mm. Ongoing pregnancy was determined 10-11 weeks after compulsory single blastocyst transfer. There was a significant (p<0.001) dose-response relationship for FE 999049 with respect to number of oocytes retrieved; overall and for each AMH strata. Increasing the FE 999049 dose with 10% led to an increase of 1 oocyte (95% CI: 0.65-1.30) in the high AMH stratum and 0.5 oocyte (95% CI: 0.22-0.72) in the low AMH stratum. The dose-response curves were significantly (p<0.05) different for the two strata, with 31-97% more oocytes in the high AMH stratum across FE 999049 doses. The percentage of FE 999049 patients with extreme responses (i.e. <4 or ≥20 oocytes) followed a U-shaped dose-response curve. No linear relationship was observed between FE 999049 dose and number of blastocysts, but rather a threshold relationship. The ongoing pregnancy rate was 35% for FE 999049 and unrelated to dose. A significant dose-response relationship was established between FE 999049 and number of oocytes retrieved with significantly different slopes for the low and high AMH strata.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call